Evidence map›Paper›PMID 35057739›Full record

Observational studyBMC medical research methodology2022

Poor reporting quality of observational clinical studies comparing treatments of COVID-19 - a retrospective cross-sectional study.

Sebastian Ziemann, Irina Paetzolt, Linda Grüßer, Mark Coburn, Rolf Rossaint, Ana Kowark

Abstract readObservational Study
In one paragraph

Observational study in BMC medical research methodology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sebastian ZiemannDepartment of Anaesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. sziemann@ukaachen.de.ORCID 0000-0003-4485-6030
Irina PaetzoltDepartment of Anaesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Linda GrüßerDepartment of Anaesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Mark CoburnDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Rolf RossaintDepartment of Anaesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Ana KowarkDepartment of Anaesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the COVID-19 pandemic, the scientific world is in urgent need for new evidence on the treatment of COVID patients. The reporting quality is crucial for transparent scientific publication. Concerns of data integrity, methodology and transparency were raised. Here, we assessed the adherence of observational studies comparing treatments of COVID 19 to the STROBE checklist in 2020.

methodsDesign: We performed a retrospective, cross-sectional study.

settingWe conducted a systematic literature search in the Medline database. This study was performed at the RWTH Aachen University Hospital, Department of Anaesthesiology Participants: We extracted all observational studies on the treatment of COVID-19 patients from the year 2020.

main outcome measuresThe adherence of each publication to the STROBE checklist items was analysed. The journals' impact factor (IF), the country of origin, the kind of investigated treatment and the month of publication were assessed.

resultsWe analysed 147 observational studies and found a mean adherence of 45.6% to the STROBE checklist items. The percentage adherence per publication correlated significantly with the journals' IF (point estimate for the difference between 1

conclusionsWe conclude a poor reporting quality of observational studies on the treatment of COVID-19 throughout the year 2020. A considerable improvement is mandatory.

Indexed as

COVID-19Cross-Sectional StudiesHumansPandemicsRetrospective StudiesSARS-CoV-2United StatesCOVID-19Observational studiesReporting qualitySTROBE statement

Identifiers

PMID35057739
PMCPMC8771183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.